GB9700624D0 - Drug delivery composition - Google Patents

Drug delivery composition

Info

Publication number
GB9700624D0
GB9700624D0 GBGB9700624.1A GB9700624A GB9700624D0 GB 9700624 D0 GB9700624 D0 GB 9700624D0 GB 9700624 A GB9700624 A GB 9700624A GB 9700624 D0 GB9700624 D0 GB 9700624D0
Authority
GB
United Kingdom
Prior art keywords
drug delivery
delivery composition
bioadhesive
microspheres
polymeric material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9700624.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Priority to GBGB9700624.1A priority Critical patent/GB9700624D0/en
Publication of GB9700624D0 publication Critical patent/GB9700624D0/en
Priority to ZA9800273A priority patent/ZA98273B/xx
Priority to PT98900600T priority patent/PT952822E/pt
Priority to EP98900600A priority patent/EP0952822B1/en
Priority to US09/341,546 priority patent/US6465626B1/en
Priority to DE69812887T priority patent/DE69812887T2/de
Priority to GB9916018A priority patent/GB2335357B/en
Priority to AU55689/98A priority patent/AU725460B2/en
Priority to AT98900600T priority patent/ATE235889T1/de
Priority to CA002275717A priority patent/CA2275717C/en
Priority to DK98900600T priority patent/DK0952822T3/da
Priority to JP53067598A priority patent/JP2001508061A/ja
Priority to ES98900600T priority patent/ES2200306T3/es
Priority to PCT/GB1998/000108 priority patent/WO1998030207A1/en
Priority to NZ335815A priority patent/NZ335815A/en
Priority to NO993195A priority patent/NO993195L/no
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9700624.1A 1997-01-14 1997-01-14 Drug delivery composition Pending GB9700624D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB9700624.1A GB9700624D0 (en) 1997-01-14 1997-01-14 Drug delivery composition
ZA9800273A ZA98273B (en) 1997-01-14 1998-01-13 Drug delivery composition produced from a mixture of gelatin and chitosan.
NZ335815A NZ335815A (en) 1997-01-14 1998-01-14 Drug delivery compositions for mucosal surfaces including microparticles comprising chitosan and type A cationic gelatin and a therapeutic agent and use
GB9916018A GB2335357B (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles
CA002275717A CA2275717C (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles
US09/341,546 US6465626B1 (en) 1997-01-14 1998-01-14 Pharmaceutical compositions of chitosan with type-A gelatin
DE69812887T DE69812887T2 (de) 1997-01-14 1998-01-14 Mikropartikel aus chitosan-gelatin a
PT98900600T PT952822E (pt) 1997-01-14 1998-01-14 Microparticulas de gelatina a e quitosano
AU55689/98A AU725460B2 (en) 1997-01-14 1998-01-14 Chitosan-gelatin A microparticles
AT98900600T ATE235889T1 (de) 1997-01-14 1998-01-14 Mikropartikel aus chitosan-gelatin a
EP98900600A EP0952822B1 (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles
DK98900600T DK0952822T3 (da) 1997-01-14 1998-01-14 Mikropartikler af chitosan-gelatine A
JP53067598A JP2001508061A (ja) 1997-01-14 1998-01-14 キトサン−ゼラチンａ微粒子
ES98900600T ES2200306T3 (es) 1997-01-14 1998-01-14 Micro-particulas de gelatina de kitosan a.
PCT/GB1998/000108 WO1998030207A1 (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles
NO993195A NO993195L (no) 1997-01-14 1999-06-28 Blanding for administrasjon av medikamenter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700624.1A GB9700624D0 (en) 1997-01-14 1997-01-14 Drug delivery composition

Publications (1)

Publication Number Publication Date
GB9700624D0 true GB9700624D0 (en) 1997-03-05

Family

ID=10805925

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9700624.1A Pending GB9700624D0 (en) 1997-01-14 1997-01-14 Drug delivery composition
GB9916018A Expired - Fee Related GB2335357B (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9916018A Expired - Fee Related GB2335357B (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles

Country Status (15)

Country Link
US (1) US6465626B1 (enExample)
EP (1) EP0952822B1 (enExample)
JP (1) JP2001508061A (enExample)
AT (1) ATE235889T1 (enExample)
AU (1) AU725460B2 (enExample)
CA (1) CA2275717C (enExample)
DE (1) DE69812887T2 (enExample)
DK (1) DK0952822T3 (enExample)
ES (1) ES2200306T3 (enExample)
GB (2) GB9700624D0 (enExample)
NO (1) NO993195L (enExample)
NZ (1) NZ335815A (enExample)
PT (1) PT952822E (enExample)
WO (1) WO1998030207A1 (enExample)
ZA (1) ZA98273B (enExample)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CA2327685C (en) * 1998-04-03 2008-11-18 Bm Research A/S Controlled release composition
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6916490B1 (en) 1998-07-23 2005-07-12 UAB Research Center Controlled release of bioactive substances
AU5006999A (en) * 1998-07-23 2000-02-14 Johns Hopkins University School Of Medicine, The Controlled release of bioactive substances
ATE258777T1 (de) * 1999-07-02 2004-02-15 Cognis Iberia Sl Mikrokapseln - ii
GB9924797D0 (en) * 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
GB0008411D0 (en) * 2000-04-05 2000-05-24 Vectura Ltd Pharmaceutical preparations and their manufacture
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
CA2413251C (en) * 2000-06-21 2012-06-12 Cubist Pharmaceuticals, Inc. Compositions and methods to improve the oral absorption of antimicrobial agents
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
ITMI20010347A1 (it) 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
JP2005501845A (ja) 2001-08-16 2005-01-20 メディカル リサーチ カウンシル キチン微小粒子およびそれらの医学的用途
EP1443944A1 (de) * 2001-11-12 2004-08-11 Johannes Reinmüller Pharmazeutische anwendungen von hyaluronsäure-präparaten
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US6830556B2 (en) 2002-01-08 2004-12-14 Zimmer Orthopaedic Surgical Products, Inc. Debridement extension providing irrigation and mechanical scrubbing for removal of dead, devitalized, or contaminated tissue from a wound
WO2003059848A2 (en) * 2002-01-10 2003-07-24 Northeastern University Hybrid immobilized catalytic system with controlled permeability
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
MXPA05010379A (es) 2003-03-27 2006-05-31 Bioactis Ltd Aparato para administrar una medicina en polvo en la cavidad intranasal.
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
AU2004235744A1 (en) * 2003-05-01 2004-11-18 Archimedes Development Limited Nasal administration of the LH-RH analog leuprolide
CN100381110C (zh) * 2003-06-16 2008-04-16 洛马林达大学医学中心 可展开的止血剂
WO2005002510A2 (en) * 2003-06-16 2005-01-13 Loma Linda University Medical Center Deployable multifunctional hemostatic agent
US20050118238A1 (en) * 2003-06-16 2005-06-02 Zhu Yong H. Deployable hemostatic agent
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0329918D0 (en) 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
JP4694214B2 (ja) * 2004-02-20 2011-06-08 ローム株式会社 比較器、ａｄ変換回路、半導体装置、および撮像装置
WO2005081866A2 (en) 2004-02-23 2005-09-09 Loma Linda University Medical Center Hemostatic agent for topical and internal use
US20070292502A1 (en) * 2004-03-23 2007-12-20 Lytone Enterprise Inc. Chitosan-Embedded or Encapsulated Capsule
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
AU2005240189A1 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
WO2005112569A2 (en) * 2004-05-13 2005-12-01 Medtronic Vascular, Inc. Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel
GB0416328D0 (en) * 2004-07-21 2004-08-25 Univ Cardiff Use of dry powder compositions for pulmonary delivery
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
DE102004059792A1 (de) 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
EP1824459A1 (en) * 2004-12-17 2007-08-29 Medipol S.A. Hydrophilic particles based on cationic chitosan derivatives
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
US8303972B2 (en) * 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
EP2974718A1 (en) * 2005-04-29 2016-01-20 Cubist Pharmaceuticals, Inc. Therapeutic compositions
JP2007006849A (ja) * 2005-07-04 2007-01-18 Japan Science & Technology Agency ６−アミノ−６−デオキシキトサン誘導体から成る核酸導入剤
US8846102B2 (en) * 2006-03-30 2014-09-30 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
AU2007262845B2 (en) 2006-06-20 2013-07-25 Mucovax Inc. Compositions comprising chitin microparticles and their medical uses
US20080248508A1 (en) * 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8741326B2 (en) * 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
JP5415769B2 (ja) * 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
GB0716907D0 (en) * 2007-08-31 2007-10-10 Archimedes Dev Ltd Pharmaceutical powder compositions
GB0722507D0 (en) * 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
DE102008059857A1 (de) * 2008-12-01 2010-06-02 Forschungsinstitut für Leder und Kunststoffbahnen gGmbH Mit Kohlenhydrat-Derivaten additivierte Gelatinezusammensetzungen
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
EP2504039A4 (en) 2009-11-25 2014-07-02 Univ Loma Linda Med HEMOSTATIC TEXTILE BASED ON CHITOSAN
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
EP3178470A1 (en) * 2011-04-11 2017-06-14 Vitux Group AS Oral pharmaceutical dispersion compositions
US8968790B2 (en) * 2011-12-09 2015-03-03 Shaker A. Mousa Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
FR2991172A1 (fr) * 2012-06-01 2013-12-06 Galderma Res & Dev Compositions pharmaceutiques topiques comprenant des microcapsules
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
US20140005379A1 (en) 2012-06-20 2014-01-02 Frank GU Nanoparticle delivery system and components thereof
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
US10182993B2 (en) 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
US12427224B1 (en) * 2015-10-15 2025-09-30 Oceanit Laboratories, Inc. Hemostatic microparticles and dressing
CA3045043A1 (en) 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
WO2019163520A1 (ja) * 2018-02-26 2019-08-29 株式会社新日本科学 粉末製剤、カートリッジ、及びデバイス
CN115154440A (zh) 2018-06-27 2022-10-11 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
NL2022788B1 (en) * 2019-03-22 2020-09-28 No Ceuticals B V Chitosan nitrate for use as a nitric oxide donor (NO donor)
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN112370437B (zh) * 2020-10-20 2022-10-21 好医生药业集团有限公司 一种阿莫西林胶囊及其制备方法
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN118304423B (zh) * 2023-05-25 2024-10-11 无锡市第二人民医院 多层级壳聚糖明胶颗粒载P4HA1 siRNA通过抑制细胞EMT治疗脑胶质瘤的研究

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
CA1219201A (en) 1983-03-07 1987-03-17 Albert E. Chu Microorganism detection test
GB8712176D0 (en) 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
CA2004270A1 (en) * 1988-12-29 1990-06-29 William R. Michael Perfume microcapsules for use in granular detergent compositions
GB8904370D0 (en) 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
BE1003677A3 (nl) 1990-01-29 1992-05-19 Schacht Etienne Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen.
EP0454444A1 (en) 1990-04-24 1991-10-30 Nissan Chemical Industries Ltd. Glutarimide derivatives and herbicides
CA2042529C (en) * 1990-08-10 2002-07-30 Chokyun Rha Polysaccharide article and uses therefor
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
GB9416884D0 (en) 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB9419979D0 (en) 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon

Also Published As

Publication number Publication date
EP0952822A1 (en) 1999-11-03
DE69812887D1 (de) 2003-05-08
NZ335815A (en) 2001-03-30
NO993195D0 (no) 1999-06-28
GB9916018D0 (en) 1999-09-08
PT952822E (pt) 2003-08-29
GB2335357A (en) 1999-09-22
CA2275717A1 (en) 1998-07-16
EP0952822B1 (en) 2003-04-02
DE69812887T2 (de) 2003-12-18
GB2335357B (en) 2000-12-13
WO1998030207A1 (en) 1998-07-16
ZA98273B (en) 1999-07-13
AU5568998A (en) 1998-08-03
DK0952822T3 (da) 2003-07-21
CA2275717C (en) 2007-09-11
US6465626B1 (en) 2002-10-15
ATE235889T1 (de) 2003-04-15
AU725460B2 (en) 2000-10-12
ES2200306T3 (es) 2004-03-01
JP2001508061A (ja) 2001-06-19
NO993195L (no) 1999-06-28

Similar Documents

Publication Publication Date Title
GB9700624D0 (en) Drug delivery composition
GB2305606A (en) Drug delivery composition for the nasal administration of antiviral agents
CA2067228A1 (en) Drug delivery system, method for preparing the same and use thereof
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
GB2341550A (en) Gastroretentive controlled release microspheres for improved drug delivery
AU1535799A (en) Pharmaceutical hydrogel formulations, drug delivery devices and methods
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
IL114193A0 (en) Ophthalmic pharmaceutical compositions
EP0871435A4 (en) THREE DIFFERENT FORMULATION OF POLYMERS WITH DELAYED RELEASE
IL109800A (en) Sustained release drug formulation containing a tramadol salt comprising cellulose ether and/or cellulose ester having a viscosity between 3,000 and 150,000 mPas
HU9603530D0 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
CA2222567A1 (en) High viscosity liquid controlled biologically active delivery system
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
CA2264238A1 (fr) Forme galenique a liberation prolongee de milnacipran
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
CA2311450A1 (en) Pharmaceutical aerosol compositions
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
EP0485840A3 (en) Pharmaceutical oral composition and coating agent containing a polysaccharide degradable in the colon
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
ZA968762B (en) Derivatives of acid pyrazoles, their preparation process, their use as medicaments, their new use and the pharmaceutical compositions containing them.
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EP0571671A1 (en) A Pharmaceutical composition in powder form
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
GB2292887A (en) Drug delivery system